Earnings Feed
Start Free
Home/Filings/4/0001209191-13-032352
4//SEC Filing

LIPOSCIENCE INC 4

Accession 0001209191-13-032352

CIK 0001168197operating
View on SEC.govCompany Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 8:45 PM ET

Size

9.4 KB

Accession

0001209191-13-032352

Insider Transaction Report

Form 4
Period: 2013-06-12
LIPOSCIENCE INCLPDX
Benson Buzz
Director
Transactions
  • Award

    Stock option (right to buy)

    2013-06-12+9,655→ 9,655 total
    Exercise: $6.68Exp: 2023-06-12→ Common Stock (9,655 underlying)
  • Award

    Common Stock

    2013-06-12+1,609→ 1,609 total
Holdings

  • Common Stock

    (indirect: By funds)
    854,210
Footnotes (5)
  • [F1]This security represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • [F2]This grant was made pursuant to the issuer's non-employee director compensation policy. As the chairman of the issuer's board of directors and a continuing director, the reporting person was awarded a number of restricted stock units equal to $10,750 divided by $6.68, the closing price of the issuer's common stock on the date of grant, June 12, 2013. The restricted stock unit award vests over a period of twelve months, with one-fourth of the shares underlying the award vesting on a quarterly basis, starting September 12, 2013, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
  • [F3]The reporting person is a Managing Director of each of (a) SightLine Healthcare Management III, L.P., the general partner of SightLine Healthcare Fund III, L.P. ("SHF III"), (b) SightLine Opportunity Management, LLC, the managing member of SightLine Healthcare Opportunity Fund, LLC ("SHOF") and (c) SightLine Vintage Management, LLC, the general partner of SightLine Healthcare Vintage Fund, L.P. ("SHVF"). The total includes 592,660 shares held by SHF III, 100,056 shares held by SHOF and 161,494 shares held by SHVF.
  • [F4]This grant was made pursuant to the issuer's non-employee director compensation policy.
  • [F5]The option vests over a period of twelve months, with one-fourth of the shares underlying the option vesting on a quarterly basis, starting September 12, 2013, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.

Documents

1 file

Issuer

LIPOSCIENCE INC

CIK 0001168197

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001168197

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 8:45 PM ET
Size
9.4 KB
View on SEC.gov